Kato J - Search Results

1

Dermoscopy of Melanoma and Non-melanoma Skin Cancers.

Kato J, Horimoto K, Sato S, Minowa T, Uhara H. Kato J, et al. Front Med (Lausanne). 2019 Aug 21;6:180. doi: 10.3389/fmed.2019.00180. eCollection 2019. Front Med (Lausanne). 2019. PMID: 31497603 Free PMC article. Review.

2

Severe atopic dermatitis associated with transient hypogammaglobulinemia of infancy.

Sumikawa Y, Kato J, Kan Y, Sato S, Yamashita T. Sumikawa Y, et al. Among authors: kato j. Int J Dermatol. 2015;54(5):e185-7. doi: 10.1111/ijd.12717. Epub 2015 Jan 20. Int J Dermatol. 2015. PMID: 25600656 No abstract available.

3

Detection of human papillomavirus type 124 in a viral wart located on a thigh.

Sato S, Kan Y, Okura M, Sumikawa Y, Kato J, Kase K, Yamashita T. Sato S, et al. Among authors: kato j. J Dermatol. 2016 Sep;43(9):1101-2. doi: 10.1111/1346-8138.13332. Epub 2016 Mar 19. J Dermatol. 2016. PMID: 26992442 No abstract available.

4

Serum cytokeratin 19 fragment 21-1 is a useful tumor marker for the assessment of extramammary Paget's disease.

Kato J, Sumikawa Y, Hida T, Kamiya T, Horimoto K, Kamiya S, Sato S, Takahashi H, Sawada M, Yamashita T. Kato J, et al. J Dermatol. 2017 Jun;44(6):666-670. doi: 10.1111/1346-8138.13760. Epub 2017 Feb 2. J Dermatol. 2017. PMID: 28150330

5

Successful TS-1 monotherapy as the second-line treatment for advanced extramammary Paget's disease: A report of two cases.

Kato J, Hida T, Yamashita T, Kamiya S, Horimoto K, Sato S, Takahashi H, Sawada M, Yamada M, Uhara H. Kato J, et al. J Dermatol. 2018 Jan;45(1):80-82. doi: 10.1111/1346-8138.14017. Epub 2017 Sep 11. J Dermatol. 2018. PMID: 28891079

6

Imiquimod 5% cream as a therapeutic option for extramammary Paget's disease.

Sawada M, Kato J, Yamashita T, Yoneta A, Hida T, Horimoto K, Sato S, Uhara H. Sawada M, et al. Among authors: kato j. J Dermatol. 2018 Feb;45(2):216-219. doi: 10.1111/1346-8138.14117. Epub 2017 Nov 8. J Dermatol. 2018. PMID: 29115681 Clinical Trial.

7

Dermoscopic features distinctive for extraocular sebaceous carcinoma.

Horimoto K, Kato J, Sumikawa Y, Hida T, Kamiya T, Sato S, Takahashi H, Sawada M, Yamashita T, Uhara H. Horimoto K, et al. Among authors: kato j. J Dermatol. 2018 Apr;45(4):487-490. doi: 10.1111/1346-8138.14170. Epub 2017 Dec 13. J Dermatol. 2018. PMID: 29235655

8

Cytokeratin 19 expression is a risk factor for metastasis in cutaneous squamous cell carcinoma.

Kato J, Hida T, Sugita S, Hasegawa T, Kamiya S, Horimoto K, Sato S, Sawada M, Uhara H. Kato J, et al. J Eur Acad Dermatol Venereol. 2018 Jul;32(7):e299-e301. doi: 10.1111/jdv.14845. Epub 2018 Mar 5. J Eur Acad Dermatol Venereol. 2018. PMID: 29419901 No abstract available.

9

Prognostic role of neutrophil to lymphocyte ratio in advanced melanoma treated with anti-programmed death-1 therapy.

Minowa T, Kato J, Hida T, Horimoto K, Sato S, Sawada M, Uhara H. Minowa T, et al. Among authors: kato j. J Dermatol. 2018 Sep;45(9):e250-e251. doi: 10.1111/1346-8138.14297. Epub 2018 Mar 23. J Dermatol. 2018. PMID: 29572922 No abstract available.

10

Rechallenge With Nivolumab After Vemurafenib Treatment of Initially Nivolumab-Resistant Advanced Melanoma.

Kato J, Hida T, Kamiya T, Sato S, Takahashi H, Torigoe T, Uhara H. Kato J, et al. JAMA Dermatol. 2018 May 1;154(5):621-622. doi: 10.1001/jamadermatol.2017.6400. JAMA Dermatol. 2018. PMID: 29590278 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,254 results

Search Page

Filters